Related Experiment Video
Updated: Oct 18, 2025

Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow
Published on: October 31, 2019
Pneumocystis primary infection in non-immunosuppressed infants in Lima, Peru
Theresa J Ochoa1, Beatriz Bustamante2, Coralith Garcia3
1Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Perú; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú.
Insights
Pneumocystis primary infection is common in Peruvian infants, particularly those aged 2-3 months during cooler seasons. Close living conditions increase the risk of Pneumocystis jirovecii transmission.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Pneumocystis primary infection is a significant concern in infants.
- Data on Pneumocystis infection in non-immunosuppressed infants is limited, especially in South America.
Purpose of the Study:
- To investigate the prevalence and risk factors of Pneumocystis primary infection in healthy infants in Lima, Peru.
- To provide original data on Pneumocystis jirovecii DNA detection in a well-baby population.
Main Methods:
- A cross-sectional study enrolled 146 infants under seven months old from Lima, Peru.
- Nasopharyngeal aspirates were analyzed for Pneumocystis jirovecii DNA using PCR.
- Demographic and clinical data were collected to identify risk factors.
Main Results:
- Pneumocystis jirovecii DNA was detected in 30.8% of infants, often without respiratory symptoms.
- Infection was more frequent in younger infants (2-3 months) and during cooler seasons (winter/spring).
- Living in crowded conditions (≤ 1 bedroom per household) was associated with higher detection rates (OR=3.03).
Conclusions:
- Pneumocystis primary infection in this Peruvian cohort is most prevalent in 2-3-month-old infants.
- Seasonal factors (winter/spring) and household crowding are associated with increased Pneumocystis detection.
- Findings highlight the importance of early detection and potential transmission routes in infants.
Objectives:
To provide original data on Pneumocystis primary infection in non-immunosuppressed infants from Peru.
Methods:
A cross sectional study was performed. Infants less than seven months old, without any underlying medical conditions attending the "well baby" outpatient clinic at one hospital in Lima, Peru were prospectively enrolled during a 15-month period from November 2016 to February 2018. All had a nasopharyngeal aspirate (NPA) for detection of P. jirovecii DNA using a PCR assay, regardless of respiratory symptoms. P. jirovecii DNA detection was considered to represent pulmonary colonization contemporaneous with Pneumocystis primary infection. Associations between infants' clinical and demographic characteristics and results of P. jirovecii DNA detection were analyzed.
Results:
P. jirovecii DNA was detected in 45 of 146 infants (30.8%) and detection was not associated with concurrent respiratory symptoms in 40 of 45 infants. Infants with P. jirovecii had a lower mean age when compared to infants not colonized (p <0.05). The highest frequency of P. jirovecii was observed in 2-3-month-old infants (p < 0.01) and in the cooler winter and spring seasons (p <0.01). Multivariable analysis showed that infants living in a home with ≤ 1 bedroom were more likely to be colonized; Odds Ratio =3.03 (95%CI 1.31-7.00; p = 0.01).
Conclusion:
Pneumocystis primary infection in this single site in Lima, Peru, was most frequently observed in 2-3-month-old infants, in winter and spring seasons, and with higher detection rates being associated with household conditions favoring close inter-individual contacts and potential transmission of P. jirovecii.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment